CFD 属于复杂的高风险金融工具，其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作，以及是否能够接受高额亏损的风险。
US 简体中文
國家 • United States
    實體 • The products and services listed on this website are not available in this location.
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    交易 BioAtla, Inc. - BCAB CFD

    2.98
    1.02%
    • 概括
    • 历史数据
    • 活动
    • 收入报表
    • 资产负债表
    • 现金流
    • 所有权
    交易条件
    价差 0.05
    多头隔夜费

    Long position overnight fee

    Margin. Your investment $1,000.00
    隔夜费用 -0.025457 %
    Charges from borrowed part ($-1.02)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    前往平台
    		-0.025457%
    空头隔夜费

    Short position overnight fee

    Margin. Your investment $1,000.00
    隔夜费用 0.003235 %
    Charges from borrowed part ($0.13)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    前往平台
    		0.003235%
    隔夜费时间 21:00 (UTC)
    最小交易量 1
    货币 USD
    保证金 20%
    上市交易所 United States of America
    交易费 0%

    *Information provided by Capital.com

    Bioatla Inc ESG Risk Ratings

    High Medium Low Negligible

    ‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

    关键数据
    前收盘价* 2.95
    开仓* 2.85
    1 年变化* -4.36%
    日范围* 2.82 - 3.02
    52 周范围 2.22-12.15
    平均交易量（10 天） 264.95K
    平均交易量（3 个月) 10.68M
    市值 147.29M
    市盈率 -100.00K
    流通股 48.88M
    收入 N/A
    EPS -2.67
    股息（收益率 %） N/A
    贝塔 -100.00K
    下一个财报发布日期 Aug 7, 2023

    所有数据都是由Refinitiv提供的， 除了标有星号的数据， 这是*由 Capital.com 提供的数据

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date 平仓 Change Change (%) 開倉 High Low
    Jun 29, 2022 2.98 0.09 3.11% 2.89 3.02 2.80
    Jun 28, 2022 2.95 -0.03 -1.01% 2.98 3.05 2.85
    Jun 27, 2022 3.03 -0.45 -12.93% 3.48 3.49 2.94
    Jun 24, 2022 3.50 0.36 11.46% 3.14 3.51 3.01
    Jun 23, 2022 2.98 0.04 1.36% 2.94 2.99 2.80
    Jun 22, 2022 2.92 0.31 11.88% 2.61 2.99 2.60
    Jun 21, 2022 2.71 -0.16 -5.57% 2.87 2.87 2.58
    Jun 17, 2022 2.59 0.09 3.60% 2.50 2.73 2.47
    Jun 16, 2022 2.45 -0.10 -3.92% 2.55 2.59 2.41
    Jun 15, 2022 2.63 0.07 2.73% 2.56 2.71 2.56
    Jun 14, 2022 2.65 -0.01 -0.38% 2.66 2.72 2.56
    Jun 13, 2022 2.64 -0.17 -6.05% 2.81 2.85 2.55
    Jun 10, 2022 2.92 -0.19 -6.11% 3.11 3.25 2.84
    Jun 9, 2022 3.01 0.08 2.73% 2.93 3.07 2.89
    Jun 8, 2022 3.02 0.07 2.37% 2.95 3.08 2.93
    Jun 7, 2022 3.06 0.48 18.60% 2.58 3.07 2.58
    Jun 6, 2022 2.66 0.08 3.10% 2.58 2.79 2.58
    Jun 3, 2022 2.72 0.43 18.78% 2.29 2.74 2.29
    Jun 2, 2022 2.39 0.14 6.22% 2.25 2.45 2.24
    Jun 1, 2022 2.31 -0.09 -3.75% 2.40 2.47 2.26

    BioAtla, Inc. Events

    时间（协调世界时） (UTC) 国家/地区 事件
    Wednesday, June 14, 2023

    时间（协调世界时） (UTC)

    15:00

    国家/地区

    US

    事件

    Bioatla Inc Annual Shareholders Meeting
    Bioatla Inc Annual Shareholders Meeting

    Forecast

    -

    Previous

    -
    Monday, August 7, 2023

    时间（协调世界时） (UTC)

    20:00

    国家/地区

    US

    事件

    Q2 2023 Bioatla Inc Earnings Release
    Q2 2023 Bioatla Inc Earnings Release

    Forecast

    -

    Previous

    -
    Wednesday, November 1, 2023

    时间（协调世界时） (UTC)

    10:59

    国家/地区

    US

    事件

    Q3 2023 Bioatla Inc Earnings Release
    Q3 2023 Bioatla Inc Earnings Release

    Forecast

    -

    Previous

    -
    查看所有活動
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    总收入 0 0.25 0.429 5.2 10.627
    收入 0 0.25 0.429 5.2 10.627
    总营业费用 108.14 96 33.411 33.468 38.861
    销售/一般/行政费用，总计 28.793 38.416 10.595 7.549 12.556
    研究与开发 79.347 58.274 19.933 25.919 26.305
    异常费用（收入） 0 -0.69 2.883 0 0
    营业收入 -108.14 -95.75 -32.982 -28.268 -28.234
    利息收入（费用），非经营净值 1.648 0.347 -2.87 -1.565 -0.74
    其他，净值 0.01 0.001 -0.001 -0.022 -0.005
    税前净收入 -106.482 -95.402 -35.853 -29.855 -28.979
    税后净收入 -106.482 -95.402 -35.853 -29.855 -28.979
    少数股东权益 0 0 0.061 0
    未计算非常项目前的净收益 -106.482 -95.402 -35.853 -29.794 -28.979
    净收入 -106.482 -95.402 -35.853 -29.794 -28.979
    Total Adjustments to Net Income 1.063 0.815
    普通股股东可获收益 (不含非经常性项目) -106.482 -95.402 -35.853 -28.731 -28.164
    普通股股东可获收益 (含非經常性項目) -106.482 -95.402 -35.853 -28.731 -28.164
    摊薄净收入 -106.482 -95.402 -35.853 -28.731 -28.164
    摊薄后加权平均股 38.9273 34.5612 32.0886 32.0886 32.0886
    扣除特别项目的每股摊薄盈利 -2.73541 -2.76038 -1.11731 -0.89536 -0.87769
    Dividends per Share - Common Stock Primary Issue 0 0 0
    每股正常摊薄盈利 -2.73541 -2.78034 -1.02747 -0.89536 -0.87769
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    总收入 0 0 0 0 0
    收入 0 0 0 0
    总营业费用 28.93 28.56 26.179 29.055 24.346
    销售/一般/行政费用，总计 7.233 6.686 6.34 8.344 7.423
    研究与开发 21.697 21.874 19.839 20.711 16.923
    营业收入 -28.93 -28.56 -26.179 -29.055 -24.346
    利息收入（费用），非经营净值 1.48 1.047 0.37 0.146 0.085
    税前净收入 -27.46 -27.543 -25.779 -28.906 -24.254
    税后净收入 -27.46 -27.543 -25.779 -28.906 -24.254
    未计算非常项目前的净收益 -27.46 -27.543 -25.779 -28.906 -24.254
    净收入 -27.46 -27.543 -25.779 -28.906 -24.254
    普通股股东可获收益 (不含非经常性项目) -27.46 -27.543 -25.779 -28.906 -24.254
    普通股股东可获收益 (含非經常性項目) -27.46 -27.543 -25.779 -28.906 -24.254
    摊薄净收入 -27.46 -27.543 -25.779 -28.906 -24.254
    摊薄后加权平均股 47.5784 43.4475 37.5168 37.5403 37.3224
    扣除特别项目的每股摊薄盈利 -0.57715 -0.63394 -0.68713 -0.77 -0.64985
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    每股正常摊薄盈利 -0.57715 -0.63394 -0.68713 -0.77 -0.64985
    异常费用（收入） 0 0
    其他，净值 -0.01 -0.03 0.03 0.003 0.007
    少数股东权益
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    流动资产总额 220.431 247.292 240.681 4.507 12.662
    现金和短期投资 215.507 244.979 238.605 3.704 10.863
    现金等价物 215.507 244.979 238.605 3.704 10.863
    Prepaid Expenses 4.924 2.313 2.076 0.803 1.799
    Total Assets 225.736 254.422 244.937 9.336 16.637
    Property/Plant/Equipment, Total - Net 5.151 6.976 4.102 4.675 3.878
    Property/Plant/Equipment, Total - Gross 10.515 11.233 7.172 6.889 5.258
    Accumulated Depreciation, Total -5.364 -4.257 -3.07 -2.214 -1.38
    Other Long Term Assets, Total 0.154 0.154 0.154 0.154 0.097
    Total Current Liabilities 23.131 19.813 32.261 26.718 9.196
    Accounts Payable 4.231 1.179 2.456 5.139 1.961
    Payable/Accrued 13.928 14.574 6.808 4.536 4.866
    Accrued Expenses 4.972 4.06 2.804 5.55 1.864
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 0 9.706 0
    Other Current Liabilities, Total 0 20.193 1.787 0.505
    Total Liabilities 45.397 43.601 34.963 65.3 45.102
    Total Long Term Debt 0 0 0.682 8.414 15
    Long Term Debt 0 0.682 8.414 15
    Minority Interest 0 -0.047 0.019
    Other Liabilities, Total 22.266 23.788 2.02 30.215 20.887
    Total Equity 180.339 210.821 209.974 -55.964 -28.465
    Redeemable Preferred Stock 0 0 89.345 89.345
    Common Stock 0.005 0.004 0.003 0.75 0.75
    Additional Paid-In Capital 473.135 397.136 300.888 2.295 0
    Retained Earnings (Accumulated Deficit) -292.801 -186.319 -90.917 -148.354 -118.56
    Total Liabilities & Shareholders’ Equity 225.736 254.422 244.937 9.336 16.637
    Total Common Shares Outstanding 47.5481 37.2913 33.6636 32.0886 32.0886
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    流动资产总额 199.717 220.431 183.309 207.197 224.019
    现金和短期投资 192.687 215.507 178.12 202.29 219.428
    现金等价物 192.687 215.507 178.12 202.29 219.428
    Prepaid Expenses 7.03 4.924 5.189 4.907 4.591
    Total Assets 204.552 225.736 189.112 213.496 230.653
    Property/Plant/Equipment, Total - Net 4.681 5.151 5.649 6.144 6.48
    Property/Plant/Equipment, Total - Gross 10.339 10.515 10.791 10.991 11.041
    Accumulated Depreciation, Total -5.658 -5.364 -5.142 -4.847 -4.561
    Other Long Term Assets, Total 0.154 0.154 0.154 0.155 0.154
    Total Current Liabilities 26.256 23.131 23.825 25.507 17.186
    Accounts Payable 8.054 4.231 3.696 4.822 1.199
    Payable/Accrued 15.367 13.928 15.652 17.377 13.518
    Accrued Expenses 2.835 4.972 4.477 3.308 2.469
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total
    Total Liabilities 48.125 45.397 46.478 48.544 40.6
    Total Long Term Debt 0 0 0 0 0
    Long Term Debt
    Other Liabilities, Total 21.869 22.266 22.653 23.037 23.414
    Total Equity 156.427 180.339 142.634 164.952 190.053
    Redeemable Preferred Stock 0 0 0
    Common Stock 0.005 0.005 0.004 0.004 0.004
    Additional Paid-In Capital 476.683 473.135 407.888 404.427 400.622
    Retained Earnings (Accumulated Deficit) -320.261 -292.801 -265.258 -239.479 -210.573
    Total Liabilities & Shareholders’ Equity 204.552 225.736 189.112 213.496 230.653
    Total Common Shares Outstanding 47.6373 47.5481 37.5773 37.4855 37.3833
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    净收入/起跑线 -106.482 -95.402 -35.853 -29.855 -28.979
    经营活动产生的现金 -90.42 -62.214 -36.334 -9.645 -35.317
    经营活动产生的现金 1.199 1.33 1.008 0.86 0.794
    非现金物品 14.576 24.434 1.873 -4.476 3.519
    营运资金的变化 0.287 7.424 -3.362 23.826 -10.651
    投资活动产生的现金 -0.265 -0.924 -0.59 -1.509 -0.988
    资本支出 -0.268 -0.924 -0.59 -1.509 -0.988
    融资活动产生的现金 61.213 69.512 271.825 3.995 5.019
    融资现金流项目 -0.758 -1.911 200.21 -0.005 0.019
    股票的发行（报废），净额 61.971 71.423 68.183 0 0
    债务的发行（退还），净额 0 3.432 4 5
    现金净变化 -29.472 6.374 234.901 -7.159 -31.286
    其他投资现金流量项目，总计 0.003
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -27.46 -106.482 -78.939 -53.16 -24.254
    Cash From Operating Activities -22.654 -90.42 -66.073 -42.057 -25.136
    Cash From Operating Activities 0.293 1.199 0.901 0.601 0.313
    Non-Cash Items 3.614 14.576 11.068 7.48 3.632
    Changes in Working Capital 0.899 0.287 0.897 3.022 -4.827
    Cash From Investing Activities -0.05 -0.265 -0.234 -0.176 -0.01
    Capital Expenditures -0.05 -0.268 -0.237 -0.179 -0.01
    Cash From Financing Activities -0.116 61.213 -0.552 -0.456 -0.405
    Financing Cash Flow Items -0.116 -0.758 -0.571 -0.475 -0.405
    Issuance (Retirement) of Debt, Net
    Net Change in Cash -22.82 -29.472 -66.859 -42.689 -25.551
    Issuance (Retirement) of Stock, Net 61.971 0.019 0.019
    Other Investing Cash Flow Items, Total 0.003 0.003 0.003
    投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
    Soleus Capital Management, L.P. Hedge Fund 9.0653 4321197 100800 2023-03-31 HIGH
    OrbiMed Advisors, LLC Investment Advisor/Hedge Fund 8.0999 3861000 3528628 2023-03-31 LOW
    Tang Capital Management, LLC Hedge Fund 7.6028 3624076 500000 2023-03-31 MED
    Short (Jay M) Individual Investor 6.3894 3045673 -2888 2023-04-30 LOW
    Acorn Bioventures L.P. Venture Capital 5.7197 2726455 2726455 2023-04-20 MED
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 4.035 1923375 -7664 2023-03-31 LOW
    Morgan Stanley & Co. LLC Research Firm 3.9125 1865000 201095 2023-03-31 MED
    Adage Capital Management, L.P. Hedge Fund 3.346 1594942 -155058 2023-03-31 LOW
    Candriam Belgium S.A. Investment Advisor/Hedge Fund 3.284 1565406 -240000 2023-03-31 LOW
    Candriam Luxembourg S.A. Investment Advisor 3.1217 1488059 -240000 2023-03-31 HIGH
    HBM Healthcare Investments (Cayman) Ltd. Corporation 2.9943 1427317 -1263552 2021-12-31 LOW
    Pfizer Inc Corporation 2.8784 1372052 -866038 2021-12-31 MED
    Wasatch Global Investors Inc Investment Advisor/Hedge Fund 2.6604 1268169 689193 2023-03-31 LOW
    Cormorant Asset Management, LP Hedge Fund 2.4778 1181115 0 2023-03-31 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 1.7485 833461 -33987 2023-03-31 LOW
    MFS Investment Management Investment Advisor/Hedge Fund 1.6092 767082 110800 2023-03-31 LOW
    Boxer Capital, L.L.C. Hedge Fund 1.4399 686347 0 2023-03-31 LOW
    Two Sigma Investments, LP Hedge Fund 1.3569 646781 8589 2023-03-31 HIGH
    Vivo Capital, LLC Venture Capital 1.3367 637181 0 2023-03-31 LOW
    Avidity Partners Management LP Hedge Fund 1.264 602500 -657500 2023-03-31 HIGH

    为什么选择 Capital.com？让我们的数字来说话。

    Capital.com Group

    530K+

    交易者

    87K+

    每月活跃客户

    $46M+

    每月投资额

    $31M+

    每月提取金额

    交易计算器

    如果您在特定日期（选择一个日期）开立差价合约交易并在不同日期（选择一个日期）关闭交易，计算您的假设盈亏。

    交易佣金
    0
    • 1:1
    杠杆
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    投资
    交易规模（杠杆 x 投资）：
    開倉

    平仓

    做空 做多
    過去的表現並不是未來結果的可靠指標
    盈利/盈利/亏损

    BioAtla, Inc. Company profile

    关于 BioAtla Inc.

    BioAtla, Inc.是一家处于临床阶段的生物制药公司。 公司专注于开发用于治疗实体瘤癌症的抗体疗法。 其候选产品包括BA3011、BA3021、BA3071。 其主要候选产品BA3011是一种针对AXL的条件活性生物制剂（CAB）抗体-药物结合物（ADC）。其第二个候选产品BA3021是一种针对ROR2的CAB ADC。 其第三个候选产品BA3071是一种CAB抗CTLA-4抗体。 公司还利用其CAB技术开发双特异性抗体，这种抗体利用CAB抗原结合域同时结合肿瘤特异性抗原和T细胞受体。 其双特异性候选产品包括BA3182、BA3142、EGFR和Nectin-4。

    Industry: Biotechnology & Medical Research (NEC)

    11085 Torreyana Road
    SAN DIEGO
    CALIFORNIA 92121
    US

    收入报表

    • Annual
    • Quarterly

    人们也观看

    Oil - Crude

    72.68 Price
    -0.340% 1D Chg, %
    多头隔夜费 -0.0154%
    空头隔夜费 -0.0065%
    隔夜费时间 21:00 (UTC)
    价差 0.03

    US100

    14,345.80 Price
    +0.140% 1D Chg, %
    多头隔夜费 -0.0255%
    空头隔夜费 0.0032%
    隔夜费时间 21:00 (UTC)
    价差 1.8

    Gold

    1,946.32 Price
    -0.030% 1D Chg, %
    多头隔夜费 -0.0185%
    空头隔夜费 0.0103%
    隔夜费时间 21:00 (UTC)
    价差 0.30

    BTC/USD

    27,927.05 Price
    +1.210% 1D Chg, %
    多头隔夜费 -0.0616%
    空头隔夜费 0.0137%
    隔夜费时间 21:00 (UTC)
    价差 60.00

    还在找一位您可以信任的经纪商吗？

    加入成为全球530,000万多名交易者的一份子，选择利用Capital.com进行交易吧。

    1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易